Posterior cortical atrophy as an extreme phenotype of GRN mutations

JAMA Neurology

Volumn 72, Issue 2, 2015, Pages 224-228

  Caroppo, Paola ^a,b,c,d   Belin, Catherine ^e   Grabli, David ^a,b,c,d   Maillet, Didier ^e   De Septenville, Anne ^a,b,c,d   Migliaccio, Raffaella ^b,c,d   Clot, Fabienne ^d   Lamari, Foudil ^d   Camuzat, Agnès ^a,b,c,d   Brice, Alexis ^a,b,c,d   Dubois, Bruno ^a,b,c,d   Le Ber, Isabelle ^a,b,c,d  

^a SORBONNE UNIVERSITÉ   (France)

^b INSERM   (France)

^c CNRS   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e AVICENNE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; PROGRANULIN; GRN PROTEIN, HUMAN; SIGNAL PEPTIDE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BRAIN CORTEX ATROPHY; CASE REPORT; CEREBRAL BLINDNESS; DEMENTIA; FAMILY HISTORY; GENE MUTATION; GENETIC ANALYSIS; GRN GENE; HETEROZYGOSITY; HUMAN; MALE; PATHOGENESIS; PERCEPTION DISORDER; PHENOTYPE; VISUAL IMPAIRMENT; ATROPHY; BRAIN CORTEX; DEGENERATIVE DISEASE; GENETICS; MIDDLE AGED; MUTATION; PATHOLOGY; PATHOPHYSIOLOGY; PEDIGREE; SYNDROME;

ATROPHY; CEREBRAL CORTEX; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; MUTATION; NEURODEGENERATIVE DISEASES; PEDIGREE; PHENOTYPE; SYNDROME;

EID: 84922968525     PISSN: 21686149     EISSN: 21686157     Source Type: Journal    
DOI: 10.1001/jamaneurol.2014.3308     Document Type: Article

References (16)

1. Crutch SJ, Lehmann M, Schott JM, Rabinovici GD, Rossor MN, Fox NC. Posterior cortical atrophy. Lancet Neurol. 2012;11(2):170-178.
2. McMonagle P, Deering F, Berliner Y, Kertesz A. The cognitive profile of posterior cortical atrophy. Neurology. 2006;66(3):331-338.
3. Alladi S, Xuereb J, Bak T, et al. Focal cortical presentations of Alzheimer's disease. Brain. 2007; 130(pt 10):2636-2645.
4. Renner JA, Burns JM, Hou CE, McKeel DW Jr, Storandt M, Morris JC. Progressive posterior cortical dysfunction: a clinicopathologic series. Neurology. 2004;63(7):1175-1180.
5. Migliaccio R, Agosta F, Rascovsky K, et al. Clinical syndromes associated with posterior atrophy: early age at onset AD spectrum. Neurology. 2009;73(19): 1571-1578.
6. Sitek EJ, Narozanska E, Pepłonska B, et al. A patient with posterior cortical atrophy possesses a novel mutation in the presenilin 1 gene. PLoS One. 2013;8(4):e61074. doi:10.1371/journal.pone.0061074.
7. Depaz R, Haik S, Peoc'h K, et al. Long-standing prion dementia manifesting as posterior cortical atrophy. Alzheimer Dis Assoc Disord. 2012;26(3): 289-292.
8. Caixeta L. Huntington's disease presenting as posterior cortical atrophy. Arq Neuropsiquiatr. 2011; 69(2B):407-408.
9. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
10. Le Ber I, Camuzat A, Hannequin D, et al; French Research Network on FTD/FTD-MND. Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study. Brain. 2008;131(pt 3):732-746.
11. Whitwell JL, Weigand SD, Boeve BF, et al. Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics. Brain. 2012;135(pt 3):794-806.
12. Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314(5796):130-133.
13. Perry DC, Lehmann M, Yokoyama JS, et al. Progranulin mutations as risk factors for Alzheimer disease. JAMA Neurol. 2013;70(6):774-778.
14. Carrasquillo MM, Khan Qu, Murray ME, et al. Late-onset Alzheimer disease genetic variants in posterior cortical atrophy and posterior AD. Neurology. 2014;82(16):1455-1462.
15. Kas A, de Souza LC, Samri D, et al. Neural correlates of cognitive impairment in posterior cortical atrophy. Brain. 2011;134(pt 5):1464-1478.
16. Rossi G, Bastone A, Piccoli E, et al. Different mutations at V363 MAPT codon are associated with atypical clinical phenotypes and show unusual structural and functional features. Neurobiol Aging. 2014;35(2):408-417.